Prediction of Childhood Epilepsy Outcome in Bangladesh

Not Applicable

Completed

• Conditions: Epilepsy

• Registration Number: NCT00381537
• Lead Sponsor: Institute of Child Health

Brief Summary

Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-09-27
• Study First Submitted QC: 2006-09-27
• Study First Posted: 2006-09-28
• Status Verified: 2006-12
• Last Update Submitted: 2006-12-22
• Last Update Posted: 2006-12-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 92

Inclusion Criteria

• Active epilepsy
• Aged 2-15 years

Exclusion Criteria

• Excluded absence
• Myoclonic and malignant epilepsy syndromes
• Major motor and cognitive impairments
• Those currently receiving antiepilepsy drugs.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (2)

Institute of Child Health; 🇬🇧 London, United Kingdom

Children's Hospital Dhaka (Shishu) Bangladesh.; 🇧🇩 Sher-e-Bangla Nagar, Dhaka 1207, Bangladesh